A citation-based method for searching scientific literature

Suresh K Balasubramanian, Mayur Sharma, Danilo Silva, Vidhya Karivedu, Philipp Schmitt, Glen H Stevens, Gene H Barnett, Richard A Prayson, Paul Elson, John H Suh, Erin S Murphy, Samuel T Chao. J Neurooncol 2017
Times Cited: 19







List of co-cited articles
97 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Outcome and survival following primary and repeat surgery for World Health Organization Grade III meningiomas.
Michael E Sughrue, Nader Sanai, Gopal Shangari, Andrew T Parsa, Mitchel S Berger, Michael W McDermott. J Neurosurg 2010
96
63

Prognostic factors for patients with atypical or malignant meningiomas treated at a single center.
Peng Zhao, Mengqing Hu, Meng Zhao, Xiaohui Ren, Zhongli Jiang. Neurosurg Rev 2015
45
63

The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.
David N Louis, Arie Perry, Guido Reifenberger, Andreas von Deimling, Dominique Figarella-Branger, Webster K Cavenee, Hiroko Ohgaki, Otmar D Wiestler, Paul Kleihues, David W Ellison. Acta Neuropathol 2016
57

Survival in patients treated for anaplastic meningioma.
Jennifer Moliterno, William P Cope, Emma D Vartanian, Anne S Reiner, Roselyn Kellen, Shahiba Q Ogilvie, Jason T Huse, Philip H Gutin. J Neurosurg 2015
56
57

WHO grade II and III meningiomas: a study of prognostic factors.
Anne Durand, François Labrousse, Anne Jouvet, Luc Bauchet, Michel Kalamaridès, Philippe Menei, Robert Deruty, Jean Jacques Moreau, Michelle Fèvre-Montange, Jacques Guyotat. J Neurooncol 2009
204
47

Long-term outcome after radiotherapy in patients with atypical and malignant meningiomas--clinical results in 85 patients treated in a single institution leading to optimized guidelines for early radiation therapy.
Sebastian Adeberg, Christian Hartmann, Thomas Welzel, Stefan Rieken, Daniel Habermehl, Andreas von Deimling, Jürgen Debus, Stephanie E Combs. Int J Radiat Oncol Biol Phys 2012
101
42


De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.
Matthieu Peyre, Guillaume Gauchotte, Marine Giry, Sébastien Froehlich, Johan Pallud, Thomas Graillon, Franck Bielle, Dominique Cazals-Hatem, Pascale Varlet, Dominique Figarella-Branger,[...]. Neuro Oncol 2018
42
42


Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution.
Lewis A Rosenberg, Richard A Prayson, Joung Lee, Chandana Reddy, Samuel T Chao, Gene H Barnett, Michael A Vogelbaum, John H Suh. Int J Radiat Oncol Biol Phys 2009
82
36

World Health Organization grade III meningiomas. A retrospective study for outcome and prognostic factors assessment.
Charles Champeaux, Elena Wilson, Sebastian Brandner, Colin Shieff, Lewis Thorne. Br J Neurosurg 2015
29
31

An evidence-based treatment algorithm for the management of WHO Grade II and III meningiomas.
Sam Q Sun, Ammar H Hawasli, Jiayi Huang, Michael R Chicoine, Albert H Kim. Neurosurg Focus 2015
82
31

Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features.
S-Y Yang, C-K Park, S-H Park, D G Kim, Y S Chung, H-W Jung. J Neurol Neurosurg Psychiatry 2008
187
31

Malignant meningioma: an indication for initial aggressive surgery and adjuvant radiotherapy.
T W Dziuk, S Woo, E B Butler, J Thornby, R Grossman, W S Dennis, H Lu, L S Carpenter, J K Chiu. J Neurooncol 1998
192
31

Prognostic factors and the management of anaplastic meningioma.
Gui-Jun Zhang, Yun-Sheng Zhang, Guo-Bin Zhang, Da Li, Li-Wei Zhang, Zhen Wu, Jun-Ting Zhang. Clin Neurol Neurosurg 2018
9
66

Meningioma grading: an analysis of histologic parameters.
A Perry, S L Stafford, B W Scheithauer, V J Suman, C M Lohse. Am J Surg Pathol 1997
454
26

Meningiomas: knowledge base, treatment outcomes, and uncertainties. A RANO review.
Leland Rogers, Igor Barani, Marc Chamberlain, Thomas J Kaley, Michael McDermott, Jeffrey Raizer, David Schiff, Damien C Weber, Patrick Y Wen, Michael A Vogelbaum. J Neurosurg 2015
311
26

Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases.
L Palma, P Celli, C Franco, L Cervoni, G Cantore. J Neurosurg 1997
208
26

Adjuvant radiotherapy for atypical and malignant meningiomas: a systematic review.
Gurvinder Kaur, Eli T Sayegh, Andrew Larson, Orin Bloch, Michelle Madden, Matthew Z Sun, Igor J Barani, C David James, Andrew T Parsa. Neuro Oncol 2014
128
26

Anaplastic meningioma: an analysis of the National Cancer Database from 2004 to 2012.
Andrew Orton, Jonathan Frandsen, Randy Jensen, Dennis C Shrieve, Gita Suneja. J Neurosurg 2018
18
27

Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
Lingyang Hua, Hongda Zhu, Jingrun Li, Hailiang Tang, Dapeng Kuang, Yin Wang, Feng Tang, Xiancheng Chen, Liangfu Zhou, Qing Xie,[...]. J Neurosurg 2018
19
26

The 2007 WHO classification of tumours of the central nervous system.
David N Louis, Hiroko Ohgaki, Otmar D Wiestler, Webster K Cavenee, Peter C Burger, Anne Jouvet, Bernd W Scheithauer, Paul Kleihues. Acta Neuropathol 2007
21

Radiotherapy for atypical or malignant intracranial meningioma.
M F Milosevic, P J Frost, N J Laperriere, C S Wong, W J Simpson. Int J Radiat Oncol Biol Phys 1996
162
21

Management of atypical and malignant meningiomas: role of high-dose, 3D-conformal radiation therapy.
E B Hug, A Devries, A F Thornton, J E Munzenride, F S Pardo, E T Hedley-Whyte, M R Bussiere, R Ojemann. J Neurooncol 2000
217
21

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Quinn T Ostrom, Haley Gittleman, Jordonna Fulop, Max Liu, Rachel Blanda, Courtney Kromer, Yingli Wolinsky, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2015
21

Analysis of prognostic factors and treatment of anaplastic meningioma in China.
Hongda Zhu, Qing Xie, Yu Zhou, Hong Chen, Ying Mao, Ping Zhong, Kang Zheng, Yongfei Wang, Yin Wang, Liqian Xie,[...]. J Clin Neurosci 2015
19
21

Survival rates, prognostic factors and treatment of anaplastic meningiomas.
Xiaoyu Cao, Shuyu Hao, Zhen Wu, Liang Wang, Guijun Jia, Liwei Zhang, Junting Zhang. J Clin Neurosci 2015
16
25

DNA methylation-based classification and grading system for meningioma: a multicentre, retrospective analysis.
Felix Sahm, Daniel Schrimpf, Damian Stichel, David T W Jones, Thomas Hielscher, Sebastian Schefzyk, Konstantin Okonechnikov, Christian Koelsche, David E Reuss, David Capper,[...]. Lancet Oncol 2017
341
21

World Health Organization Grade III (Nonanaplastic) Meningioma: Experience in a Series of 23 Cases.
Gui-Jun Zhang, Guo-Bin Zhang, Yun-Sheng Zhang, Huan Li, Cheng-Bei Li, Li-Wei Zhang, Da Li, Zhen Wu, Jun-Ting Zhang. World Neurosurg 2018
11
36

Prognostic factors for patients with World Health Organization grade III meningiomas treated at a single center.
Baoyin Shan, Jing Zhang, Yanlin Song, Jianguo Xu. Medicine (Baltimore) 2017
7
57

EANO guidelines for the diagnosis and treatment of meningiomas.
Roland Goldbrunner, Giuseppe Minniti, Matthias Preusser, Michael D Jenkinson, Kita Sallabanda, Emmanuel Houdart, Andreas von Deimling, Pantelis Stavrinou, Florence Lefranc, Morten Lund-Johansen,[...]. Lancet Oncol 2016
390
21

Survival and Prognostic Predictors of Anaplastic Meningiomas.
Waseem Masalha, Dieter Henrik Heiland, Daniel Delev, Jamina Tara Fennell, Pamela Franco, Christian Scheiwe, Bianca-Ioana Mercas, Irina Mader, Oliver Schnell, Juergen Grauvogel. World Neurosurg 2019
10
40

A review of malignant meningiomas: diagnosis, characteristics, and treatment.
Simon Hanft, Peter Canoll, Jeffrey N Bruce. J Neurooncol 2010
70
15

Efficacy of postoperative radiotherapy for high grade meningiomas.
Yunseon Choi, Do Hoon Lim, Kyungil Jo, Do-Hyun Nam, Ho Jun Seol, Jung-Il Lee. J Neurooncol 2014
25
15

Ki-67 proliferative index predicts clinical outcome in patients with atypical or anaplastic meningioma.
Jordi Bruna, Marta Brell, Isidre Ferrer, Pepita Gimenez-Bonafe, Avelina Tortosa. Neuropathology 2007
122
15

Review of controversies in management of non-benign meningioma.
Iddo Paldor, Mohammed Awad, Yuval Z Sufaro, Andrew H Kaye, Yigal Shoshan. J Clin Neurosci 2016
25
15

Epidemiology of meningiomas post-Public Law 107-206: The Benign Brain Tumor Cancer Registries Amendment Act.
Therese A Dolecek, Emily Van Meter Dressler, Jigisha P Thakkar, Meng Liu, Abeer Al-Qaisi, John L Villano. Cancer 2015
68
15

The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Ellen Abry, Ingrid Ø Thomassen, Øyvind O Salvesen, Sverre H Torp. Pathol Res Pract 2010
92
15

Atypical and malignant meningioma: outcome and prognostic factors in 119 irradiated patients. A multicenter, retrospective study of the Rare Cancer Network.
David Pasquier, Stefan Bijmolt, Theo Veninga, Nicolas Rezvoy, Salvador Villa, Marco Krengli, Damien C Weber, Brigitta G Baumert, Emine Canyilmaz, Deniz Yalman,[...]. Int J Radiat Oncol Biol Phys 2008
158
15

Descriptive epidemiology of World Health Organization grades II and III intracranial meningiomas in the United States.
Varun R Kshettry, Quinn T Ostrom, Carol Kruchko, Ossama Al-Mefty, Gene H Barnett, Jill S Barnholtz-Sloan. Neuro Oncol 2015
105
15

"Malignancy" in meningiomas: a clinicopathologic study of 116 patients, with grading implications.
A Perry, B W Scheithauer, S L Stafford, C M Lohse, P C Wollan. Cancer 1999
435
15

Extent of resection and overall survival for patients with atypical and malignant meningioma.
Ayal A Aizer, Wenya Linda Bi, Manjinder S Kandola, Eudocia Q Lee, Lakshmi Nayak, Mikael L Rinne, Andrew D Norden, Rameen Beroukhim, David A Reardon, Patrick Y Wen,[...]. Cancer 2015
96
15


High incidence of activating TERT promoter mutations in meningiomas undergoing malignant progression.
Stéphane Goutagny, Jean C Nault, Maxime Mallet, Dominique Henin, Jessica Z Rossi, Michel Kalamarides. Brain Pathol 2014
160
15

Anatomic location is a risk factor for atypical and malignant meningiomas.
Ari J Kane, Michael E Sughrue, Martin J Rutkowski, Gopal Shangari, Shanna Fang, Michael W McDermott, Mitchel S Berger, Andrew T Parsa. Cancer 2011
119
15

Pathology concordance levels for meningioma classification and grading in NRG Oncology RTOG Trial 0539.
C Leland Rogers, Arie Perry, Stephanie Pugh, Michael A Vogelbaum, David Brachman, William McMillan, Joseph Jenrette, Igor Barani, Dennis Shrieve, Andy Sloan,[...]. Neuro Oncol 2016
64
15

Long term clinical outcomes of malignant meningiomas.
Yu Seok Lim, Min Ki Kim, Bong Jin Park, Tae Sung Kim, Young Jin Lim. Brain Tumor Res Treat 2013
11
27

Atypical and anaplastic meningioma: outcomes in a population based study.
T Garzon-Muvdi, W Yang, M Lim, H Brem, J Huang. J Neurooncol 2017
24
15

Atypical and malignant meningioma: outcome and prognostic factors in 68 irradiated patients.
Beatrice Detti, Silvia Scoccianti, Vanessa Di Cataldo, Eleonora Monteleone, Samantha Cipressi, Lorenzo Bordi, Gianni Pellicanò, Davide Gadda, Calogero Saieva, Daniela Greto,[...]. J Neurooncol 2013
34
15

Epidemiology of intracranial meningioma.
Elizabeth B Claus, Melissa L Bondy, Joellen M Schildkraut, Joseph L Wiemels, Margaret Wrensch, Peter M Black. Neurosurgery 2005
346
15


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.